MARKSANS — Marksans Pharma Share News
0.000.00%
- IN₹130.01bn
- IN₹123.80bn
- IN₹29.51bn
Brief: Marksans Pharma Gets Communication From USFDA On Verification Of NDMA In Metformin Extended Release Tablets
Brief: Marksans Pharma -India Ratings & Research (Fitch Group) Revised Co's Outlook To Positive From Stable
Brief: India's Marksans Pharma Dec-Quarter Consol Profit Rises
Brief: Marksans Pharma Gets FDA Establishment Inspection Report At Farmingdale, NY Manufacturing Facility
Brief: India's Marksans Pharma Sept-Qtr Consol Profit Rises
Brief: India's Marksans Pharma June Quarter Consol Profit Falls
Brief: India's Marksans Pharma March-Qtr Profit Rises
Brief: Marksans Pharma Says U.S. FDA Inspection Of Goa Facility Resulted In Form 483 With 8 Observations
Brief: India's Marksans Pharma Dec-Qtr Profit Rises
Brief: Marksans Pharma Says UK MHRA Grants Marketing Authorisation For Loratadine Oral Solution
Brief: India's Marksans Pharma Sept-Qtr Consol Profit Rises
Brief: India's Marksans Pharma June-Qtr Consol Profit Rises
Brief: India's Marksans Pharma Posts March-Qtr Profit
Brief: India's Marksans Pharma Dec-Qtr Consol Profit Rises
Brief: India's Marksans Pharma Sept-qtr consol profit rises
Brief: Marksans Pharma gets EIR from U.S. FDA for inspection of Goa facility
Brief: India's Marksans Pharma June-qtr profit falls
Brief: Marksans Pharma's Goa plant gets approved by UK MHRA
Brief: Marksans Pharma gets GMP compliance certificate from Australian health dept.